BioAlliance Pharma Receives €4.3 Million in Funding from bpifrance (ex OSEO) To Accelerate the Industrial Development of Li...
03 Juli 2013 - 6:00PM
Business Wire
Grant to support NICE: France’s first
nanomedicine consortium led by BioAlliance Pharma
Biotest (TG:BIO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Biotest (TG:BIO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Biotest AG (Tradegate (DE)): 0 Nachrichtenartikel
Weitere BioAlliance Pharma SA News-Artikel